United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

salmon) 50units/1ml solution for injection ampoules (a a h pharmaceuticals ltd - calcitonin (salmon) - solution for injection - 50unit/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

salmon) 400units/2ml solution for injection vials (a a h pharmaceuticals ltd - calcitonin (salmon) - solution for injection - 200unit/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

salmon) 100units/1ml solution for injection ampoules (a a h pharmaceuticals ltd - calcitonin (salmon) - solution for injection - 100unit/1ml

United States - English - NLM (National Library of Medicine)

mylan institutional llc - calcitonin salmon (unii: 7sfc6u2vi5) (calcitonin salmon - unii:7sfc6u2vi5) - miacalcin injection is indicated for the treatment of symptomatic paget’s disease of bone in patients with moderate to severe disease characterized by polyostotic involvement with elevated serum alkaline phosphatase and urinary hydroxyproline excretion. there is no evidence that the prophylactic use of calcitonin salmon is beneficial in asymptomatic patients. miacalcin injection should be used only in patients who do not respond to alternative treatments or for whom such treatments are not suitable (e.g., patients for whom other therapies are contraindicated or for patients who are intolerant or unwilling to use other therapies). miacalcin injection is indicated for the early treatment of hypercalcemic emergencies, along with other appropriate agents, when a rapid decrease in serum calcium is required, until more specific treatment of the underlying disease can be accomplished. it may also be added to existing therapeutic regimens for hypercalcemia such as intravenous fluids and furosemide, oral phosphate or

United States - English - NLM (National Library of Medicine)

mylan institutional llc - calcitonin salmon (unii: 7sfc6u2vi5) (calcitonin salmon - unii:7sfc6u2vi5) - miacalcin injection is indicated for the treatment of symptomatic paget’s disease of bone in patients with moderate to severe disease characterized by polyostotic involvement with elevated serum alkaline phosphatase and urinary hydroxyproline excretion. there is no evidence that the prophylactic use of calcitonin salmon is beneficial in asymptomatic patients. miacalcin injection should be used only in patients who do not respond to alternative treatments or for whom such treatments are not suitable (e.g., patients for whom other therapies are contraindicated or for patients who are intolerant or unwilling to use other therapies). miacalcin injection is indicated for the early treatment of hypercalcemic emergencies, along with other appropriate agents, when a rapid decrease in serum calcium is required, until more specific treatment of the underlying disease can be accomplished. it may also be added to existing therapeutic regimens for hypercalcemia such as intravenous fluids and furosemide, oral phosphate or

Australia - English - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - calcitonin salmon, quantity: 50 iu/ml - injection, solution - excipient ingredients: water for injections; glacial acetic acid; sodium chloride; sodium acetate - - active paget's diseasein patients who do not respond to alternative treatments or for whom such treatments are not suitable,- hypercalcaemia.

Ireland - English - HPRA (Health Products Regulatory Authority)

essential pharma ltd - calcitonin, salmon - solution for injection/infusion - 100 international unit(s)/millilitre - calcitonin preparations; calcitonin (salmon synthetic)

Canada - English - Health Canada

sandoz canada incorporated - calcitonin (salmon synthetic) - liquid - 200unit - calcitonin (salmon synthetic) 200unit - parathyroid and antiparathyroid agents

Canada - English - Health Canada

apotex inc - calcitonin (salmon synthetic) - solution - 200unit - calcitonin (salmon synthetic) 200unit - parathyroid and antiparathyroid agents

Canada - English - Health Canada

pro doc limitee - calcitonin (salmon synthetic) - solution - 200unit - calcitonin (salmon synthetic) 200unit - parathyroid and antiparathyroid agents